CrossrefInfokarte
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Rheumatology and Therapy · 2025-02 · 12 (1) · 173-202
DOI: 10.1007/s40744-024-00736-4 ↗Abstract
Kein Abstract verfügbar.
EUVIMED